The first part of the event was dedicated to the eClinical solutions. Data MATRIX CEO Ivan Dobromyslov presented a review of clinical trial solutions development, and spoke about the influence of current regulatory and management requirements on the products. He also analyzed special aspects of patient-centric research, described new opportunities of trials with mobile devices and specificity of projects with big databases. Data MATRIX COO Kristina Leus demonstrated the process of leading the project through the MATRIX CTMS.
OCT Medical writer Evgeniya Radkova moderated the second session. She introduces the speakers – Director Statistical Analytics Oncolology Clinical Development Pfizer Dmitry Pavlov and Federal Research and Clinical Center of Physical-Chemical Medicine Biostatistician Irina Bondareva. In terms of their speeches and discussions with the audience, the new trends in early clinical trials were covered. The participants got acquainted with the software for clinical data analysis and validation, as well as with special products for sample size determination, adaptive design, modeling, pharmacokinetick analysis, etc.
The meeting was finished with a Q&A-session. More than 100 guests attended the conference.